Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
G Shabazz
Observed name:
Gabri’el D. Shabazz
Institution:
National Pharmaceutical Council
Observed institution:
National Pharmaceutical Council
ORCID:
0009-0007-3160-4797
Observed ORCID:
0009-0007-3160-4797
OpenAlex ID:
A5099138460
CMS’s Drug Price Negotiation Program 2023 Patient-Focused Listening Sessions: A Descriptive Analysis of Speaker Remarks
2024
·
Julie A. Patterson
, Tyler D. Wagner
, et al.
·
PharmacoEconomics - Open
PDF
HPR30 Variation in per Beneficiary Prescription Utilization and Spending By Race/Ethnicity in Medicare and Medicaid Insurance Claims
2024
·
TD Wagner
, M Sahu
, et al.
·
Value in Health
PDF
HPR58 Mapping Medicaid: A Comparative Analysis of State-Level Racial and Ethnic Data Collection to Federal Guidelines
2024
·
RK Salih
, JD Campbell
, et al.
·
Value in Health
PDF
HPR105 Breadth of Patient and Stakeholder Input in CMS's Drug Price Negotiation Program: A Content Analysis of the 2023 Patient-Focused Listening Sessions
2024
·
J Patterson
, TD Wagner
, et al.
·
Value in Health
Show more works
View as search
Works count:
4
Citation count:
H-index:
I10-index:
Year
Topic
Type
